The impact of hepatitis C burden: an evidence-based approach. (Q38181631)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

The impact of hepatitis C burden: an evidence-based approach (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

Z M Younossi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

F Kanwal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S Saab

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

K A Brown

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

H B El-Serag

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

A Ahmed

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

M Kugelmas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

S C Gordon

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

English

0 references

publication date

26 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

6 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

518-531

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

The Institute of Medicine report on viral hepatitis: a call to action

6 March 2020

cites work

1 reference

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

21 January 2018

1 reference

Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma

21 January 2018

1 reference

Natural history of acute and chronic hepatitis C.

21 January 2018

1 reference

Mortality in patients with chronic and cleared hepatitis C viral infection: a nationwide cohort study

21 January 2018

1 reference

No impact of hepatitis C virus infection on mortality among drug users during the first decade after seroconversion

21 January 2018

1 reference

Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study

21 January 2018

1 reference

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

21 January 2018

1 reference

All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population

21 January 2018

1 reference

Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study.

21 January 2018

1 reference

Associations of chronic hepatitis C with metabolic and cardiac outcomes

21 January 2018

1 reference

Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors

21 January 2018

1 reference

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

21 January 2018

1 reference

Economic burden of hepatitis C-associated diseases in the United States.

21 January 2018

1 reference

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

Impact of disease severity on healthcare costs in patients with chronic hepatitis C (CHC) virus infection

21 January 2018

1 reference

Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement

21 January 2018

1 reference

Interferon-free hepatitis C therapy: how close are we?

21 January 2018

1 reference

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression

21 January 2018

1 reference

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

21 January 2018

1 reference

Review article: non-alcoholic fatty liver disease and hepatitis C--risk factors and clinical implications

21 January 2018

1 reference

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

21 January 2018

1 reference

Role of hepatitis C virus genotype 3 in liver fibrosis progression--a systematic review and meta-analysis

21 January 2018

1 reference

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

21 January 2018

1 reference

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans

21 January 2018

1 reference

Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.

21 January 2018

1 reference

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

21 January 2018

1 reference

Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies

21 January 2018

1 reference

Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection.

21 January 2018

1 reference

Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis

21 January 2018

1 reference

Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis.

21 January 2018

1 reference

Adverse outcomes in Alaska natives who recovered from or have chronic hepatitis C infection

21 January 2018

1 reference

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study

21 January 2018

1 reference

Survival of a national cohort of hepatitis C virus infected patients, 16 years after exposure

21 January 2018

1 reference

Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.

21 January 2018

1 reference

Effects and outcomes of interferon treatment in Japanese hepatitis C patients

21 January 2018

1 reference

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

21 January 2018

1 reference

Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway

21 January 2018

1 reference

Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status

21 January 2018

1 reference

Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study

21 January 2018

1 reference

Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

21 January 2018

1 reference

Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study

21 January 2018

1 reference

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.

21 January 2018

1 reference

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C.

21 January 2018

1 reference

Chronic hepatitis C virus infection: prevalence of extrahepatic manifestations and association with cryoglobulinemia in Bulgarian patients

21 January 2018

1 reference

Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt

21 January 2018

1 reference

Prospective study of hepatitis C viral infection as a risk factor for subsequent B-cell neoplasia

21 January 2018

1 reference

Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening

21 January 2018

1 reference

Evidence for association between hepatitis C virus seropositivity and coronary artery disease

21 January 2018

1 reference

Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area

21 January 2018

1 reference

Hepatitis C virus infection and increased risk of cerebrovascular disease.

21 January 2018

1 reference

The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C

21 January 2018

1 reference

Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan.

21 January 2018

1 reference

Hepatitis C virus kinetics during and immediately after liver transplantation.

21 January 2018

1 reference

The natural history of recurrent hepatitis C and what influences this

21 January 2018

1 reference

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

21 January 2018

1 reference

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

The association between hepatitis C infection and survival after orthotopic liver transplantation

21 January 2018

1 reference

Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients.

21 January 2018

1 reference

Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States

21 January 2018

1 reference

No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data

21 January 2018

1 reference

Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis.

21 January 2018

1 reference

How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?

21 January 2018

1 reference

A longitudinal analysis of hepatitis C virus replication following liver transplantation

21 January 2018

1 reference

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome

21 January 2018

1 reference

Hepatitis C is a risk factor for death after liver retransplantation

21 January 2018

1 reference

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

21 January 2018

1 reference

Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation

21 January 2018

1 reference

Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation.

21 January 2018

1 reference

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

21 January 2018

1 reference

All-cause and liver-related mortality in hepatitis C infected drug users followed for 33 years: a controlled study.

21 January 2018

1 reference

Long-term follow-up among Danish transfusion recipients identified in the national hepatitis C lookback.

21 January 2018

1 reference

Outcome of sustained virological responders with histologically advanced chronic hepatitis C.

21 January 2018

1 reference

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

21 January 2018

1 reference

Effect of hepatitis C virus and its treatment on survival

21 January 2018

1 reference

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

21 January 2018

1 reference

Diagnosis, management, and treatment of hepatitis C: an update

21 January 2018

1 reference

Humanistic and economic impacts of hepatitis C infection in the United States

21 January 2018

1 reference

Economic burden associated with patients diagnosed with hepatitis C.

21 January 2018

1 reference

Direct economic burden of chronic hepatitis C virus in a United States managed care population

21 January 2018

1 reference

Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.

21 January 2018

1 reference

Burden of gastrointestinal disease in the United States: 2012 update

21 January 2018

1 reference

21 January 2018

1 reference

Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection

21 January 2018

1 reference

Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment.

21 January 2018

1 reference

Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12625

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24461160%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference